Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
How has the insulin infusion pump market size changed in recent years, and what is the outlook ahead?
The insulin infusion pump market size has grown rapidly in recent years. It will grow from $6.33 billion in 2024 to $6.99 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to increasing incidence and prevalence of diabetic patients, rising rate of obesity, growing demand for these integrated systems, increasing awareness and education, and improving reimbursement policies.
The insulin infusion pump market size is expected to rapid growth in the next few years. It will grow to $10.31 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to expanding access to telehealth services, increasing cases of chronic diseases, rising demand for personalized medicine, increasing healthcare expenditure, and growing awareness amongst the physicians and patients. Major trends in the forecast period include advancements in closed-loop systems, integration of artificial intelligence (AI) and machine learning, technological developments in wireless connectivity, advancements in pump miniaturization, and integration with wearable devices.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24256&type=smp
What are the top economic and technological drivers pushing insulin infusion pump market growth?
The growing prevalence of diabetes is expected to propel the growth of the insulin infusion pump market going forward. Diabetes is a chronic medical condition where the body is unable to properly regulate blood sugar or glucose levels. The growing prevalence of diabetes is mainly driven by increasing sedentary lifestyles and poor dietary habits that leads to obesity, insulin resistance, and higher rates of type 2 diabetes. Insulin infusion pumps help in diabetes management by delivering continuous and precise insulin doses, maintaining stable blood glucose levels. They reduce the need for frequent injections, offering convenience and better control over blood sugar, enhancing overall diabetes care. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the increase in lifestyle-related diseases is expected to drive the growth of the medical device safety testing market.
How is the insulin infusion pump market segmented by product, application, and end-user?
The insulin infusion pump market covered in this report is segmented –
1) By Type: Continuous Subcutaneous Insulin Infusion Pumps, Insulin Delivery Pens, Wearable Insulin Pumps
2) By Technology: Remote Monitoring Systems, Closed Loop Systems, Smart Insulin Pumps
3) By End Use: Hospitals, Home Care Settings, Diabetes Clinics
Subsegments:
1) By Continuous Subcutaneous Insulin Infusion (CSII) Pumps: Tubed Insulin Pumps, Tubeless Insulin Pumps, Closed-Loop Systems, Smart Insulin Pumps
2) By Insulin Delivery Pens: Reusable Insulin Pens, Disposable Insulin Pens, Smart Insulin Pens
3) By Wearable Insulin Pumps: Adhesive Patch Pumps, Detachable Patch Pumps, Hybrid Closed-Loop Wearables
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/insulin-infusion-pump-global-market-report
What evolving trends are creating new opportunities in the insulin infusion pump market?
Major companies operating in the insulin infusion pumps market are focusing on developing innovative products, such as insulin patch pump systems, to improve convenience, enhance portability, and provide more discreet and comfortable insulin delivery options for patients. Insulin patch pump systems refer to small, wearable devices that deliver insulin through the skin without the need for traditional tubing. For instance, in November 2023, ViCentra BV, a Netherlands-based medical device company, launched a hybrid closed-loop system for automated insulin delivery that combines its Kaleido insulin patch pump with the Diabeloop DBLG1 algorithm and Dexcom G6 continuous glucose monitoring. This integrated artificial pancreas automatically adjusts insulin dosing in real time, significantly reducing hypoglycemia and improving glucose control and time in range for people with type 1 diabetes. The system is user-friendly, requires minimal setup without fingerstick tests, and uploads data to a cloud platform for easy monitoring by users and healthcare providers.
Which leading companies are dominating the insulin infusion pump market landscape?
Major companies operating in the insulin infusion pump market are Pfizer Inc., Roche Holding AG, Sanofi S.A., Medtronic plc, Eli Lilly and Company, Becton, Dickinson and Company, Baxter International Inc., Terumo Corporation, Smiths Group plc, Moog Inc., ICU Medical Inc., Insulet Corporation, MicroPort Scientific Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, B. Braun Melsungen AG, Beta Bionics Inc., SOOIL Development Co. Ltd., Fresenius SE & Co. KGaA, Shinmyung Mediyes Co. Ltd.
Which geographic areas are expected to offer the highest growth opportunities in theinsulin infusion pump market?
North America was the largest region in the insulin infusion pump market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin infusion pump market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Insulin Infusion Pump Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/customise?id=24256&type=smp
Need Customized Data On Insulin Infusion Pump Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24256&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
